Web Analytics

3 Latest Announced Rounds

$2,291.00M Raised in 71 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Exeliom Biosciences

start up
France - Dijon, Bourgogne-Franche-Comté
  • 21/07/2023
  • Series A
  • $8,898,320

At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication


Related People

Benjamin HadidaFounder

Benjamin Hadida France - Paris, Île-de-France

Biotech company builder and new therapeutic class explorer